Emvision Medical Devices Ltd (EMV) - Net Assets
Based on the latest financial reports, Emvision Medical Devices Ltd (EMV) has net assets worth AU$19.74 Million AUD (≈ $13.97 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$24.94 Million ≈ $17.65 Million USD) and total liabilities (AU$5.20 Million ≈ $3.68 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Emvision Medical Devices Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$19.74 Million |
| % of Total Assets | 79.14% |
| Annual Growth Rate | 32.73% |
| 5-Year Change | -7.67% |
| 10-Year Change | N/A |
| Growth Volatility | 124.95 |
Emvision Medical Devices Ltd - Net Assets Trend (2018–2025)
This chart illustrates how Emvision Medical Devices Ltd's net assets have evolved over time, based on quarterly financial data. See EMV defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Emvision Medical Devices Ltd (2018–2025)
The table below shows the annual net assets of Emvision Medical Devices Ltd from 2018 to 2025. For live valuation and market cap data, see Emvision Medical Devices Ltd market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | AU$9.28 Million ≈ $6.57 Million |
-49.86% |
| 2024-06-30 | AU$18.52 Million ≈ $13.10 Million |
+261.99% |
| 2023-06-30 | AU$5.12 Million ≈ $3.62 Million |
-27.77% |
| 2022-06-30 | AU$7.08 Million ≈ $5.01 Million |
-29.57% |
| 2021-06-30 | AU$10.05 Million ≈ $7.11 Million |
+82.01% |
| 2020-06-30 | AU$5.52 Million ≈ $3.91 Million |
+20.00% |
| 2019-06-30 | AU$4.60 Million ≈ $3.26 Million |
+259.88% |
| 2018-06-30 | AU$1.28 Million ≈ $905.05K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Emvision Medical Devices Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 3397116600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$41.75 Million | 449.77% |
| Other Comprehensive Income | AU$2.35 Million | 25.28% |
| Total Equity | AU$9.28 Million | 100.00% |
Emvision Medical Devices Ltd Competitors by Market Cap
The table below lists competitors of Emvision Medical Devices Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Poongwon Precision Co. Ltd.
KQ:371950
|
$104.59 Million |
|
Ester Industries Limited
NSE:ESTER
|
$104.59 Million |
|
Climb Global Solutions
NASDAQ:CLMB
|
$104.60 Million |
|
Singha Estate Public Company Limited
BK:S
|
$104.68 Million |
|
KOMPLETT ASA NK -40
F:GJ60
|
$104.55 Million |
|
Tait Marketing & Distribution Co Ltd
TWO:5902
|
$104.50 Million |
|
Nien Hsing Textile Co Ltd
TW:1451
|
$104.49 Million |
|
CastleNet Technology
TWO:8059
|
$104.45 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Emvision Medical Devices Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 18,515,748 to 9,282,964, a change of -9,232,784 (-49.9%).
- Net loss of 9,805,536 reduced equity.
- Share repurchases of 2,380 reduced equity.
- Other comprehensive income decreased equity by 1,111,492.
- Other factors increased equity by 1,689,008.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-9.81 Million | -105.63% |
| Share Repurchases | AU$2.38K | -0.03% |
| Other Comprehensive Income | AU$-1.11 Million | -11.97% |
| Other Changes | AU$1.69 Million | +18.19% |
| Total Change | AU$- | -49.86% |
Book Value vs Market Value Analysis
This analysis compares Emvision Medical Devices Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 14.63x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 71.57x to 14.63x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-06-30 | AU$0.02 | AU$1.59 | x |
| 2019-06-30 | AU$0.10 | AU$1.59 | x |
| 2020-06-30 | AU$0.09 | AU$1.59 | x |
| 2021-06-30 | AU$0.14 | AU$1.59 | x |
| 2022-06-30 | AU$0.09 | AU$1.59 | x |
| 2023-06-30 | AU$0.07 | AU$1.59 | x |
| 2024-06-30 | AU$0.23 | AU$1.59 | x |
| 2025-06-30 | AU$0.11 | AU$1.59 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Emvision Medical Devices Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -105.63%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -194.10%
- • Asset Turnover: 0.32x
- • Equity Multiplier: 1.68x
- Recent ROE (-105.63%) is below the historical average (-73.52%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -66.06% | -171.52% | 0.31x | 1.26x | AU$-972.95K |
| 2019 | -64.29% | -260.67% | 0.22x | 1.10x | AU$-3.42 Million |
| 2020 | -91.92% | -517.77% | 0.16x | 1.09x | AU$-5.63 Million |
| 2021 | -83.54% | -494.36% | 0.16x | 1.07x | AU$-9.40 Million |
| 2022 | -86.27% | -140.11% | 0.51x | 1.20x | AU$-6.82 Million |
| 2023 | -75.67% | -55.51% | 0.61x | 2.25x | AU$-4.38 Million |
| 2024 | -14.74% | -24.33% | 0.47x | 1.29x | AU$-4.58 Million |
| 2025 | -105.63% | -194.10% | 0.32x | 1.68x | AU$-10.73 Million |
Industry Comparison
This section compares Emvision Medical Devices Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $194,539,512
- Average return on equity (ROE) among peers: -192.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Emvision Medical Devices Ltd (EMV) | AU$19.74 Million | -66.06% | 0.26x | $104.56 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.84 Billion |
| Adherium Ltd (ADR) | $830.00K | -1420.96% | 1.70x | $7.60 Million |
| Aroa Biosurgery Ltd (ARX) | $53.69 Million | -32.84% | 0.36x | $154.57 Million |
| Atomo Diagnostics Ltd (AT1) | $6.98 Million | -71.26% | 0.33x | $12.75 Million |
| Avita Medical Inc (AVH) | $16.23 Million | 0.00% | 0.05x | $119.77 Million |
| Anteris Technologies Global Corp (AVR) | $5.01 Million | 0.00% | 0.01x | $848.00 Million |
| Control Bionics Ltd (CBL) | $6.27 Million | -94.35% | 0.44x | $26.53 Million |
| Cardiex Ltd (CDX) | $3.28 Million | -81.11% | 0.41x | $13.23 Million |
| Compumedics Ltd (CMP) | $11.68 Million | -158.94% | 1.04x | $35.62 Million |
| Cochlear Ltd (COH) | $1.84 Billion | 19.39% | 0.49x | $5.47 Billion |
About Emvision Medical Devices Ltd
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospita… Read more